Μ. Scott Perry

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome

Ian Miller, Ingrid E. Scheffer, Boudewijn Gunning et al. · JAMA Neurology · 2020 · 248 citations · Full text

Genotype-phenotype correlations in <i>SCN8A</i> -related disorders reveal prognostic and therapeutic implications

Katrine M. Johannesen, Yuanyuan Liu, Mahmoud Koko et al. · Brain · 2021 · 138 citations · Full text

The gain of function <i>SCN1A</i> disorder spectrum: novel epilepsy phenotypes and therapeutic implications

Andreas Brunklaus, Tobias Brünger, Tony Feng et al. · Brain · 2022 · 137 citations · Full text

Neurological Disorder, Scn1a Variants Cluster, Therapeutic Implications +18

A novel de novo dominant negative mutation in <i>DNM1L</i> impairs mitochondrial fission and presents as childhood epileptic encephalopathy

Jill A. Fahrner, Raymond Liu, Μ. Scott Perry et al. · American Journal of Medical Genetics Part A · 2016 · 134 citations · Full text

Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial

Anup D. Patel, Maria Mazurkiewicz‐Bełdzińska, Richard Chin et al. · Epilepsia · 2021 · 103 citations · Full text